Who owns Biogen Idec?

Key details on Biogen Idec (Ticker: BIIB)

Who owns Biogen Idec?

Is BIIB a good stock to own? Find out who bought Biogen Idec, who sold Biogen Idec (BIIB) stock, and who holds a large position in Biogen Idec.

Fund Name Number of Shares Share Valuation As Of
FMR 19.00M $6.29B Sept. 30, 2014
PRIMECAP Management Company 17.22M $5.70B Sept. 30, 2014
Icahn Capital 12.86M $943.81M March 31, 2011
Vanguard 12.34M $4.08B Sept. 30, 2014
T. Rowe Price Associates 12.19M $3.85B June 30, 2014
Schroder Investment Management 11.19M $2.69B Sept. 30, 2013
STATE STREET CORPORATION 9.86M $3.26B Sept. 30, 2014
Capital Research Global Investors^ 8.20M $2.59B June 30, 2014
ClearBridge Advisors 7.89M $2.49B June 30, 2014
JPMORGAN CHASE & CO 6.92M $2.29B Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 6.21M $2.06B Sept. 30, 2014
Jennison Associates 5.86M $1.94B Sept. 30, 2014
Ameriprise Financial 5.67M $818.02M June 30, 2012
Wellington Management Company 5.16M $769.35M Sept. 30, 2012
Sands Capital Management 4.95M $1.64B Sept. 30, 2014
Marsico Capital Management 4.66M $899.30M March 31, 2013

Who sold Biogen Idec?

Fund Name Date Sold Number of Shares Sold Share Valuation
GOLDMAN SACHS March 31, 2011 5.99M $440.41M
Inves Dec. 31, 2010 4.90M $328.30M
Tudor Investment Corporation June 30, 2005 4.71M $162.21M